🩸 #Thalassemia is an inherited blood disorder that causes the body to produce less than the usual amount of hemoglobin. It is estimated that more than 100 million people worldwide carry genes responsible for thalassemia and that annually more than 300,000 babies are born each year with severe forms of the disease. 🔎 At Bristol Myers Squibb we put the focus on the importance of access to early diagnosis and therapies that improve the quality of life of #patients, as many of them face severe clinical complications. Find out more about thalassemia on the Thalassaemia International Federation (TIF) website ➡️ https://lnkd.in/eRA4Bhy #ITD2024 #BeAwareShareCare #TreatmentForThal #TreatmentForAll #InternationalThalassemiaDay #BMSIberia #BMSPortugal #BMSCommunity #BMSTransformingLives #WorkingTogetherforPatients #BMSTransformingPatientsLives
Bristol Myers Squibb’s Post
More Relevant Posts
-
Patients with a rare and progressive disease such as AL #Amyloidosis can present with a wide range of general symptoms that can lead to organ dysfunction and failure. We are committed to advancing scientific breakthroughs with the potential to improve outcomes for people living with this disease. Learn more about our investigational anti-amyloid treatment for AL amyloidosis: https://bit.ly/4aCCccN
To view or add a comment, sign in
-
𝗧𝗲𝗺𝗥𝗘𝗡 𝗔𝘁𝗵𝗲𝗿𝗲𝗰𝘁𝗼𝗺𝘆 𝗦𝘆𝘀𝘁𝗲𝗺. Peripheral arterial disease (PAD) is a clinical manifestation of systemic atherosclerosis and is associated with significant morbidity and mortality. The physiological force and shear stress from #angioplasty and stenting have made PAD treatment challenging. TEMREN #Atherectomy is a major therapy in the management of peripheral vascular disease. 𝐠𝐥𝐨𝐛𝐚𝐥𝐬𝐚𝐥𝐞𝐬@𝐢𝐧𝐯𝐚𝐦𝐞𝐝.𝐜𝐨𝐦
To view or add a comment, sign in
-
The analysis of pre-COVID-19 patients with Kawasaki disease (KD) requiring intensive care unit management included in the French national cohort shows that those with myocardial involvement (MyoKD) had all features of multisystemic inflammatory syndrome children (MIS-C), both characterized by the combination of gastro-intestinal system involvement, hyperinflammation, and high resistance rate to IVIG in monotherapy. This suggests that MyoKD and MIS-C might belong to a common spectrum. 🔗https://lnkd.in/dFrcQsUe
To view or add a comment, sign in
-
Management of pain crises in Sickle cell disease patients. Sickle cell disease patients have frequent bouts of moderate to severe pain. The pain may persist from a few hours to weeks. #sicklecell #sicklecellawareness #sicklecellpainmanagement #bestmedicaltourismcompany #sicklecellcomplications #cmcshealth
To view or add a comment, sign in
-
Watch this animated video article presenting the results from the phase III ELATIVE® clinical trial, which investigates elafibranor, in patients who have an inadequate response to ursodeoxycholic acid (UDCA). Learn how elafibranor could offer a new approach in treating this rare, chronic liver disease. Watch now: https://hubs.ly/Q02SmJlq0 #PBC #LiverDisease #ELATIVETrial
To view or add a comment, sign in
-
TAPS is just one of several complications that can happen with twins who share a placenta. While everything used to be categorised as twin-twin transfusion syndrome, over the past decade or so, more research has been performed. We now know that there are 4 complications that affect monochorionic twins, with different diagnostic criteria, staging systems, and treatment options. In 2021, these diseases also finally recieved their own ORPHA codes, fully recognising their disease autonomy. Learn more here: https://bit.ly/3E9rVFv #ITD2024 #tapseducation #tapstwins
To view or add a comment, sign in
-
MannKind announced today that it will proceed with a first-in-human Phase 1 study of nintedanib DPI (MNKD-201) for pulmonary fibrotic diseases – including idiopathic pulmonary fibrosis (IPF). According to @PulmonaryFibrosisFoundation, there are more than 250,000 Americans living with pulmonary fibrosis (PF) today with 50,000 new cases diagnosed each year. Sadly, as many as 40,000 Americans die from IPF each year. MannKind now has two studies in motion that will explore the potential treatment options for patients living with serious lung diseases. https://bit.ly/3Wio8lg #MNKD #Pulmonary #Lungs
To view or add a comment, sign in
-
The tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/sPAP) ratio ratio is an echocardiographic parameter associated with chronic kidney disease (CKD) in patients with systemic sclerosis, irrespective of left ventricle ejection fraction. TAPSE/sPAP ≤0.32 mm/mm Hg and CKD are also significant predictors for all-cause mortality in these patients. 🔗https://lnkd.in/dyYsZBuc
To view or add a comment, sign in
-
Dr. Ken Brown reveals how integrating ProScan technology into the management of inflammatory bowel disease offers a new layer of diagnostic precision. Especially for Crohn's disease patients with persistent symptoms but normal MRE or CTE results, ProScan serves as a critical therapeutic tool, uncovering hidden issues like aphthous ulcers. AnX's innovative approach is reshaping the treatment landscape for IBD, enhancing patient outcomes through technology. #anx #anxrobotica #irritablebowel #ibs #crohns #crohnsdisease #ibd #smallbowel #smallbowelcancer #smallbowelobstuction #smallintestine #smallintestines #smallintestinecancer #artificial_intelligence #artificialintelligence #artificialintelligencetechnology #healthtechnology #newtech #newtechnology #capsuleendoscopy
To view or add a comment, sign in
-
Ever wondered why your HbA1c results might not tell the whole story? Several factors can contribute to inaccurate HbA1c measurements: ✔️Conditions like sickle cell anemia, thalassemia, or other hemoglobinopathies. ✔️Patients who have had recent blood transfusions. ✔️Low hemoglobin levels. ✔️Patients with chronic kidney disease. ✔️Conditions that lead to increased destruction of red blood cells (like hemolytic anemia). ✔️Differences in testing methods or equipment between laboratories. What strategies do you use to verify HbA1c results in your lab? Let me know in the comments. #HBA1C #LabTests #Diabetic #BloodGlucose #AccurateResults
To view or add a comment, sign in
1,491,485 followers
More from this author
-
Developing tools to break the rules: Fostering innovation to manufacture cell therapy at scale
Bristol Myers Squibb 2w -
The next wave: Exploring diverse research platforms to bring transformational options to patients with blood disorders
Bristol Myers Squibb 1mo -
Accelerating protein degradation science with AI and machine learning
Bristol Myers Squibb 4mo